Transforming growth factor β (TGFβ) has tumor‐inhibitory activity in the early stages of prostate tumorigenesis but promotes migration, epithelial-mesenchymal transition (EMT), invasion, and metastasis in late-stage disease [15, 16]. The gene discussed is TGFB1; the disease is neoplasm.